Examines new findings that anti-CTLA-4 immunotherapy triggers a distal B-cell and antibody response in neck lymph nodes to attack brain tumors.
Key Takeaways
- It requires an intensive B-cell and antibody response initiated far away from the tumor
- Professor Lee’s lab directly challenged this view by demonstrating that in mouse glioma models
- This coordinated cellular machinery triggered an immediate spike in Immunoglobulin G (IgG)